Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 18 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $6,693 16 sh |
| Apr 21, 2026 traded Apr 20, 2026 |
| 18 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $19K 46 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 18 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $36K 84 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 18 | Eltoukhy AdamSEE REMARKS | Open-market sale · 10b5-1 plan | SELL | $3,119 100 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 18 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $21K 50 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $3.33M 19.3K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $3.00M 17.9K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $6.71M 39.3K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $4.91M 29.1K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $1.14M 6,526 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $5.53M 32.2K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $6.01M 35.4K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $7.85M 45.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 16 | Bradbury Robyn LChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $177K 3,353 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 16 | Valente ManuelaChief People Officer | Open-market sale · 10b5-1 plan | SELL | $1,977 380 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 14 | Pearson MarkDirector, President and CEO | Open-market sale · 10b5-1 plan | SELL | $1.65M 39.7K sh | Apr 21, 2026 traded Apr 20, 2026 |
| 14 | Mohan JitendraDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $644K 3,662 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 14 | Gupta VikramSee Remarks | Open-market sale · 10b5-1 plan | SELL | $125K 1,548 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $3,165 608 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Muken RossPresident | Open-market sale · 10b5-1 plan | SELL | $3,955 760 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Menu PhilippeChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $3,162 608 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Camblong JurgiDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $23K 4,486 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Van Well DaanChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $3,554 684 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 12 | Bradbury Robyn LChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $86K 1,647 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 10 | Sevalia Piyush BSee Remarks | Open-market sale · 10b5-1 plan | SELL | $1.17M 2,419 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Garateix Ernie JDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $221K 8,034 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Collins Helen LouiseCHIEF MEDICAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $117K 2,441 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Ames Sophie CExec. Vice President & CHRO | Open-market sale · 10b5-1 plan | SELL | $66K 3,070 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Collins Helen LouiseCHIEF MEDICAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $115K 2,419 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Wasechek WayneEVP and CFO | Open-market sale · 10b5-1 plan | SELL | $62K 2,920 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Lewis BryanDirector, CEO/President | Open-market sale · 10b5-1 plan | SELL | $85K 10.0K sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | Open-market sale · 10b5-1 plan | SELL | $885K 1,543 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Gibbons Mary LourdesSVP and Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $55K 872 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | Open-market sale · 10b5-1 plan | SELL | $806K 1,398 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 7 | Llewellyn Lindsay CatherineSEE REMARKS | Open-market sale · 10b5-1 plan | SELL | $355K 23.7K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 7 | Binder Kurtis JosephCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $380K 25.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 7 | Gibbons Mary LourdesSVP and Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $481K 7,628 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 5 | Garateix Ernie JDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $8,521 300 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 5 | Kuhn Hallie E.EVP - Cap Market & Co-Lead -LS | Open-market sale · 10b5-1 plan | SELL | $26K 536 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 4 | Hoffmann MartinCEO | Open-market sale · 10b5-1 plan | SELL | $152K 4,150 sh | Apr 21, 2026 traded Apr 20, 2026 |